These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33274915)

  • 1. Circumventing Myeloid-Derived Suppressor Cell-Mediated Immunosuppression Using an Oxygen-Generated and -Economized Nanoplatform.
    Zuo H; Hou Y; Yu Y; Li Z; Liu H; Liu C; He J; Miao L
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55723-55736. PubMed ID: 33274915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
    [No Abstract]   [Full Text] [Related]  

  • 3. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
    Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
    Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging.
    Yang Z; Wang J; Ai S; Sun J; Mai X; Guan W
    Theranostics; 2019; 9(23):6809-6823. PubMed ID: 31660070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
    Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
    Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
    [No Abstract]   [Full Text] [Related]  

  • 7. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
    Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
    Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoenabled Tumor Oxygenation Strategies for Overcoming Hypoxia-Associated Immunosuppression.
    Zhang C; Yan Q; Li J; Zhu Y; Zhang Y
    ACS Appl Bio Mater; 2021 Jan; 4(1):277-294. PubMed ID: 35014284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-Infrared Upconversion Mesoporous Tin Oxide Bio-Photocatalyst for H
    Feng L; Zhao R; Liu B; He F; Gai S; Chen Y; Yang P
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41047-41061. PubMed ID: 32816454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
    Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting Immunogenic Cell Death and Alleviating Myeloid-Derived Suppressor Cells by Sono-Activatable Semiconducting Polymer Nanopartners for Immunotherapy.
    Ding M; Zhang Y; Yu N; Zhou J; Zhu L; Wang X; Li J
    Adv Mater; 2023 Aug; 35(33):e2302508. PubMed ID: 37165741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment-responsive polymer with chlorin e6 to interface hollow mesoporous silica nanoparticles-loaded oxygen supply factor for boosted photodynamic therapy.
    Wang X; Ding X; Yu B; Zhang X; Shen Y; Cong H
    Nanotechnology; 2020 Jul; 31(30):305709. PubMed ID: 32299065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Oxygen-Supply Immunosuppression-Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid-Derived Suppressor Cells.
    Yang Z; Zuo H; Hou Y; Zhou S; Zhang Y; Yang W; He J; Shen X; Peng Q
    Small; 2024 Nov; 20(48):e2406860. PubMed ID: 39233543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.
    van Hooren L; Georganaki M; Huang H; Mangsbo SM; Dimberg A
    Oncotarget; 2016 Jul; 7(31):50277-50289. PubMed ID: 27385210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
    Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
    Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells.
    Zhou S; Shang Q; Ji J; Luan Y
    ACS Appl Mater Interfaces; 2021 Oct; 13(40):47407-47417. PubMed ID: 34597015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Microenvironment-Responsive Cerium-Enriched Copper Nanozyme with O
    Lin J; Huang C; Wang P; He Y; Luo Q; Liu X; Li Y
    Adv Healthc Mater; 2024 Apr; 13(11):e2303955. PubMed ID: 38271271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.